2021
DOI: 10.1002/cctc.202101498
|View full text |Cite
|
Sign up to set email alerts
|

One‐pot Multienzyme (OPME) Chemoenzymatic Synthesis of Brain Ganglioside Glycans with Human ST3GAL II Expressed in E. coli

Abstract: A human sialyltransferase ST3GAL II (hST3GAL II) was successfully expressed in Escherichia coli as an active soluble fusion protein with an N-terminal maltose-binding protein (MBP) and a C-terminal hexa-histidine tag. It was used as an efficient catalyst in a one-pot multienzyme (OPME) sialylation system for highyield production of the glycans of ganglioside GM1b and highly sialylated brain gangliosides GD1a and GT1b. Further sialylation of GM1b and GD1a glycans using a bacterial α2-8-sialyltransferase in anot… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 60 publications
(91 reference statements)
0
10
0
Order By: Relevance
“…To facilitate the purification of enzymes that will be used for glycoprotein in vitro N-glycan processing, an His 6 -tag was introduced at the C-terminus of each recombinant enzyme to allow its easy purification by Ni 2+ -affinity columns. Furthermore, we found that fusing a maltose binding protein (MBP) at the N-terminus of the target recombinant protein and removing the N-terminal transmembrane domain of mammalian glycosyltransferases by truncation worked well to improve their soluble expression in E. coli [ 47 ]. These were the strategies that guided our general design to construct the plasmids for expressing target recombinant enzymes.…”
Section: Resultsmentioning
confidence: 99%
“…To facilitate the purification of enzymes that will be used for glycoprotein in vitro N-glycan processing, an His 6 -tag was introduced at the C-terminus of each recombinant enzyme to allow its easy purification by Ni 2+ -affinity columns. Furthermore, we found that fusing a maltose binding protein (MBP) at the N-terminus of the target recombinant protein and removing the N-terminal transmembrane domain of mammalian glycosyltransferases by truncation worked well to improve their soluble expression in E. coli [ 47 ]. These were the strategies that guided our general design to construct the plasmids for expressing target recombinant enzymes.…”
Section: Resultsmentioning
confidence: 99%
“…Haemophilus ducreyi vST3Gal-I 59 (GT29) myxoma virus-infected European rabbit kidney RK13 cells hST3GAL-II 42 (GT29) human CjCst-I 41,44 (GT42) Campylobacter jejuni Sialyltransferases and mutants for synthesizing α2−6-linked sialosides Pd2,6ST 11,60,61 Campylobacter jejuni Sialic acid aldolases EcAldolase 70 Escherichia coli PmAldolase 71 Pasteurella multocida Crystal structures 72 CMP-Nonulosonic acid synthetases NmCSS 70 Neisseria meningitidis NmCSS_S81R and NmCSS_Q163A 73 Crystal structures 74 EcCSS 70 Escherichia coli SaVCSS 70 Streptococcus agalactiae PmCSS 73 Pasteurella multocida HdCSS 73 Haemophilus ducreyi LpCLS 75 Legionella pneumophila 58 although it was capable of α2−3-sialylating the unbranched Core 1 T antigen (a β1−3-linked galactoside) on glycopeptides. 43 Human ST3GAL-II uses β1−3-linked galactosides as acceptor substrates efficiently for the high-yield synthesis of the glycans of gangliosides GT1b, GD1a, and GM1b.…”
Section: (Gt80)mentioning
confidence: 99%
“…Depending on the buffer, pH, and temperature, sugar phosphates and NDP-sugars can decompose quickly within the time span relevant for enzymatic synthesis. Therefore, their formation in situ from the corresponding reducing sugar has become increasingly popular. Partially driven by their high commercial value, the advent of one-pot multienzyme approaches in the early 1990s has led to simplified access to both natural and a limited range of unnatural NDP-sugars, alongside enabling improved characterization of glycosyltransferases. This section therefore focuses only on recent advancements in one-pot, biosynthetic routes to NDP-sugars, particularly around the regeneration of expensive cofactors, which are often required stoichiometrically.…”
Section: Using Biocatalysis To Provide the Building Blocks For Bioche...mentioning
confidence: 99%